Literature DB >> 15284852

Imatinib induces a cytogenetic response in blast crisis or interferon failure chronic myeloid leukemia patients with e19a2 BCR-ABL transcripts.

J-J Lee, H-J Kim, Y-J Kim, S Lee, J-Y Hwang, Y-L Kim, D-W Kim.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15284852     DOI： 10.1038/sj.leu.2403454

Source DB:  PubMed          Journal:  Leukemia        ISSN： 0887-6924            Impact factor:   11.528


× No keyword cloud information.
  4 in total

1.  Chronic Myeloid Leukemia with e19a2 BCR-ABL1 Transcripts and Marked Thrombocytosis: The Role of Molecular Monitoring.

Authors:  Stephen E Langabeer; Sarah L McCarron; Johanna Kelly; Janusz Krawczyk; Suzanne McPherson; Kanthi Perera; Philip T Murphy
Journal:  Case Rep Hematol       Date:  2012-07-02

2.  Identification of real microRNA precursors with a pseudo structure status composition approach.

Authors:  Bin Liu; Longyun Fang; Fule Liu; Xiaolong Wang; Junjie Chen; Kuo-Chen Chou
Journal:  PLoS One       Date:  2015-03-30       Impact factor: 3.240

3.  Rapid Evolution to Blast Crisis Associated with a Q252H ABL1 Kinase Domain Mutation in e19a2 BCR-ABL1 Chronic Myeloid Leukaemia.

Authors:  Sarah L McCarron; Karena Maher; Johanna Kelly; Mary F Ryan; Stephen E Langabeer
Journal:  Case Rep Hematol       Date:  2013-09-16

Review 4.  Prognostic Significance of Transcript-Type BCR - ABL1 in Chronic Myeloid Leukemia.

Authors:  Matteo Molica; Elisabetta Abruzzese; Massimo Breccia
Journal:  Mediterr J Hematol Infect Dis       Date:  2020-09-01       Impact factor: 2.576
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.